salsolinol has been researched along with Parkinson Disease, Secondary in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, Y; Gao, H; Jin, L; Lin, L; Wang, D; Wang, Q; Zhang, W; Zheng, J; Zhu, W | 1 |
| Dostert, P; Hashizume, Y; Maruyama, W; Nakahara, D; Naoi, M; Ota, M; Takahashi, T | 1 |
| Dostert, P; Hashizume, Y; Maruyama, W; Naoi, M | 1 |
| Dostert, P; Kasamatsu, T; Maruyama, W; Naoi, M | 1 |
| Deleu, D | 1 |
| Burkhardt, K; Kaftan, A; Schwarz, J; Storch, A | 1 |
| Antkiewicz-Michaluk, L; Michaluk, J; Papla, I; Romańska, I; Vetulani, J | 1 |
| Mizuno, Y; Suzuki, K; Yoshida, M | 1 |
1 review(s) available for salsolinol and Parkinson Disease, Secondary
| Article | Year |
|---|---|
N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
Topics: Animals; Biomarkers; Brain; Cell Line; Cell Survival; Dopamine; Humans; Isoquinolines; Male; Neurotoxins; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Wistar; Salsoline Alkaloids; Stereoisomerism; Tetrahydroisoquinolines | 1997 |
7 other study(ies) available for salsolinol and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcholine; Acetylcholinesterase; Animals; Brain; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Isoquinolines; Male; Microdialysis; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Stereoisomerism | 2008 |
Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
Topics: Animals; Behavior, Animal; Biogenic Amines; Corpus Striatum; Disease Models, Animal; Injections; Isoquinolines; Male; Parkinson Disease, Secondary; Rats; Rats, Wistar; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 1996 |
Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Corpus Striatum; Cycloheximide; Disease Models, Animal; DNA Damage; Dopamine; Homovanillic Acid; Humans; Hydroxyl Radical; Isoquinolines; Male; Necrosis; Neuroblastoma; Neurons; Neurotoxins; Oxidative Stress; Parkinson Disease, Secondary; Posture; Rats; Rats, Wistar; Salsoline Alkaloids; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1998 |
Endogenous dopamine-derived neurotoxins and Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Dopamine; Humans; Isoquinolines; Methyltransferases; MPTP Poisoning; Nerve Tissue Proteins; Neurotoxins; Parkinson Disease; Parkinson Disease, Secondary; Rats; Salsoline Alkaloids; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 1998 |
1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
Topics: 1-Methyl-4-phenylpyridinium; Adenosine Triphosphate; Dopamine; Dose-Response Relationship, Drug; Electron Transport Complex I; Electron Transport Complex II; Energy Metabolism; Glucose; Herbicides; Humans; Isoquinolines; Mitochondria; Multienzyme Complexes; NAD; NADH, NADPH Oxidoreductases; Neuroblastoma; Oxidoreductases; Parkinson Disease, Secondary; Rotenone; Succinate Dehydrogenase; Tumor Cells, Cultured; Uncoupling Agents | 2000 |
Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
Topics: Animals; Antiparkinson Agents; Apomorphine; Binding, Competitive; Brain Chemistry; Catalepsy; Dopamine; Dopamine Antagonists; Haloperidol; Homovanillic Acid; Isoquinolines; Male; Motor Activity; Neurotoxins; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Wistar; Tetrahydroisoquinolines; Tritium | 2000 |
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Brain; Dose-Response Relationship, Drug; Energy Metabolism; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Parkinson Disease, Secondary; Quinone Reductases; Tetrahydroisoquinolines; Tetrahydropapaveroline | 1990 |